First Home Sperm Test device launched in India

First time in India, home sperm test device to count moving sperm has been approved by FDA. A Los Angeles based company Medical Electronic Systems (MES) which has specialization in rapid Automated Semen Analysis and announced the launch of YO® Home Sperm Test in India. YO® offers video-based smartphone platform and measure Motile Sperm Concentration (the number of moving sperm) which is a critical factor in determining male fertility. YO® is very innovative and first of its kind device in India.

YO® offers accuracy rate of 97% and a user can view and measure the number of motile (moving) sperm in their samples on their phone. This device offers the comfort of home and makes male fertility testing an easy process.

MES developed this kit to address the problem of delayed male testing and to eliminate the stressful public nature of male sperm analysis. YO® provides an accurate assessment of moving sperm concentration (MSC).

YO® provides full proof evidence with video to a user to show it to the doctor their problem and converts critical moving sperm testing easier at home. Male factor infertility test becomes very common and this device YO® will become a game changer in India and Worldwide.

Users can buy YO® Home Sperm Test kit from their website and on Amazon India for INR 1990. Users can analyze their sperm count easily and can experience/ analyze the change with making a change in their lifestyle.

 

Related Posts

Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

Dr Rajendra Pratap Gupta gets nominated to advise UN Secretary General Geneva/ New Delhi: Former advisor to Union Health Minister of India JP Nadda in his earlier stint and a…

IPC releases draft NFI-2026 to promote rational use of medicines

Ghaziabad:- The Indian Pharmacopoeia Commission (IPC) has taken a significant step toward strengthening public health systems with the draft release of the National Formulary of India (NFI) 2026, a comprehensive…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Over-the-counter sale of cough syrup barred

Over-the-counter sale of cough syrup barred

FDA seals Bhiwandi-based cosmetic factory for misleading claims, fake address

FDA seals Bhiwandi-based cosmetic factory for misleading claims, fake address

Yashoda Medicity’s AI-enabled E- ICU poised to make Quality Critical Care Universal

Yashoda Medicity’s AI-enabled E- ICU poised to make Quality Critical Care Universal

Licences no shield in NDPS cases: HC refuses bail in 1.37 crore tablets seizure

Licences no shield in NDPS cases: HC refuses bail in 1.37 crore tablets seizure

No cough syrups without a doctor’s prescription – New rules announced

No cough syrups without a doctor’s prescription – New rules announced

CSIR-IIIM launches two-month certificate course On cGMP-compliant herbal drug manufacturing

CSIR-IIIM launches two-month certificate course On cGMP-compliant herbal drug manufacturing